LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
- Status
- UNKNOWN
- Phase
- PHASE2
Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Immunotoxin Therapy in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas
- Status
- UNKNOWN
- Phase
- PHASE3
Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas
- Status
- WITHDRAWN
- Phase
- PHASE2
Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2